Case Details
- Citation: [2011] SGHC 193
- Title: D'Conceicao Jeanie Doris (administratrix of the estate of Milakov Steven, deceased) v Tong Ming Chuan
- Court: High Court of the Republic of Singapore
- Date: 22 August 2011
- Case Number: Suit No 270 of 2010
- Tribunal/Court: High Court
- Coram: Tay Yong Kwang J
- Judgment Length: 56 pages, 30,436 words
- Plaintiff/Applicant: D'Conceicao Jeanie Doris (administratrix of the estate of Milakov Steven, deceased)
- Defendant/Respondent: Tong Ming Chuan
- Parties: D'Conceicao Jeanie Doris (administratrix of the estate of Milakov Steven, deceased) — Tong Ming Chuan
- Legal Areas: Tort – Negligence – Medical Negligence
- Statutes Referenced: Civil Law Act (Cap 43, 1999 Rev Ed)
- Counsel Name(s): Mr Palaniappan S (Straits Law Practice) for the plaintiff; Mr Edwin Tong, Ms Mak Wei Munn and Mr Tham Hsu Hsien (Allen& Gledhill) for the defendant.
- Procedural Posture: Trial confined to liability
- Outcome (as to liability): Not stated in the provided extract (judgment text truncated)
Summary
This High Court decision concerns a claim in medical negligence arising from cardiothoracic surgery and subsequent post-operative complications. The plaintiff, acting as administratrix of the estate of the deceased, Milakov Steven (“MS”), sued Dr Tong Ming Chuan (“Dr Tong”), a consultant cardiothoracic surgeon, alleging that Dr Tong was negligent and/or in breach of contract in relation to the medical advice, care and treatment rendered to MS during the period from 9 March 2007 to 23 April 2007. The claim was brought for the benefit of MS’s dependants under ss 20 and 21 of the Civil Law Act, and for the benefit of MS’s estate under s 10 of the Civil Law Act.
The court’s analysis, as reflected in the extract, is structured around the medical timeline: MS suffered a first major adverse cardiac event (“MACE”) in January 2007 while in Houston, underwent an initial triple coronary artery bypass graft (“CABG”) on 19 January 2007, and later suffered a second MACE in March 2007 in Singapore. The second event involved an acute myocardial infarction (“AMI”) with angiographic evidence suggesting complete occlusion of two saphenous vein grafts. Dr Tong proposed and performed a redo-CABG on 12 March 2007, approximately seven weeks after the initial CABG, and MS died on 23 April 2007 from post-operative complications.
Although the provided judgment text is truncated before the court’s final conclusions, the case is clearly significant for its focus on liability in medical negligence, particularly where the alleged breach concerns clinical judgment and informed consent-type advice about the appropriateness and risks of a high-stakes surgical intervention performed soon after a prior major operation.
What Were the Facts of This Case?
MS was an American citizen with permanent residence status in Singapore. He had a history of borderline diabetes and hypertension but, prior to his first major adverse cardiac event, was described as having been in good health and maintaining an active lifestyle, including regular exercise. MS was engaged on a contractual basis by Chevron Inc in the United States as a consultant on communication skills, brand management and public relations, and he was also an author of books and articles. His average monthly earnings were around S$16,250 at the time of his death.
In January 2007, while in Houston, MS experienced left-side back tightness accompanied by nausea during his usual physical exercise routine. He was taken to St Joseph Medical Centre (“SJMC”), where he was diagnosed with ischaemia and angina pectoris. Importantly, the court record distinguishes these conditions from an acute myocardial infarction (“AMI”): MS did not suffer an AMI on 17 January 2007; it was his first MACE. Coronary angiography on 18 January 2007 revealed coronary artery disease with stenosis in the left main coronary artery, the left anterior descending system, the circumflex artery, and the right coronary system.
Following SJMC’s advice, MS underwent a triple CABG on 19 January 2007 (“the initial CABG”). The initial CABG involved three grafts: (1) a saphenous vein graft from the aorta to a marginal branch of the circumflex artery (“Graft 1”); (2) a saphenous vein graft from the aorta to another marginal branch of the circumflex artery (“Graft 2”); and (3) a left internal mammary artery graft to the LAD (“the LIMA-LAD graft”). The extract notes that there was a dispute at trial about the position of Graft 1, but both sides accepted that this was inconsequential for the issues being decided.
After the initial CABG, MS recovered well and returned to Singapore in February 2007. He consulted his general practitioner, who recommended cardiology follow-up with an interventional cardiologist, Dr Christopher Chew. On 23 February 2007, Dr Chew conducted tests that were within acceptable ranges and advised that MS was recovering well and could continue his usual exercises and lifestyle. Despite this, MS adopted a more sedentary lifestyle and rested at home due to being on medical leave.
On 9 March 2007, MS experienced chest pain and presented to the Accident and Emergency Department of Mount Elizabeth Hospital (“MEH”) at around 6.00am, requesting to see Dr Chew. It was not disputed that MS suffered an AMI that day, his first AMI. Dr Chew examined MS and performed a coronary angiography at about 8.45am. The angiogram suggested that Graft 1 and Graft 2 were completely occluded, with the Cardiac Catheterization Report describing a “total block”. The occlusion meant that no blood could flow through those grafts, cutting off oxygen and nutrient supply to downstream heart muscle areas. There was, however, a substantial dispute at trial about the patency of the LIMA-LAD graft, and the significance of this dispute would later become central to whether the redo-CABG was indicated and/or appropriate.
Dr Chew recommended that MS obtain a surgical opinion from a cardiothoracic surgeon, and he referred MS to Dr Tong. At or about 12.00 noon on 9 March 2007, Dr Tong examined MS and proposed the option of a redo-CABG. The extract indicates that the sufficiency of Dr Tong’s advice to MS on the risks of the redo-CABG and on alternative treatment options was disputed. On 12 March 2007, Dr Tong performed the redo-CABG. The court record emphasises that a redo-CABG is similar in principle to an initial CABG but is “much riskier”, particularly when performed within a short period after the initial surgery. The extract explains the medical rationale: after an initial CABG, the heart and surrounding tissues require time to recover; scarring and adhesions develop; and the closer the redo surgery is to the initial operation, the more vascularised the scar tissue and incision areas become, increasing blood loss. The extract truncates mid-sentence as it describes the need for careful surgical technique to manage bleeding.
What Were the Key Legal Issues?
The trial was confined to liability, meaning the court’s task was to determine whether Dr Tong owed MS a duty of care and whether he breached that duty, causing the relevant harm. In medical negligence cases, liability typically turns on whether the defendant’s conduct fell below the standard of care expected of a reasonably competent medical practitioner in the same field, and whether the breach caused or materially contributed to the injury or death complained of. While the extract does not include the later portions of the judgment, the pleaded case is clear: the plaintiff alleged negligence and/or breach of contract relating to medical advice, care and treatment between 9 March 2007 and 23 April 2007.
A central issue, as foreshadowed by the extract, is the appropriateness and indication for performing a redo-CABG in the circumstances. The court record highlights that there was a dispute about the patency of the LIMA-LAD graft, and that this dispute would be significant in assessing whether the redo-CABG was indicated and/or appropriate. This suggests that the court had to evaluate whether the surgical decision was clinically justified based on the available diagnostic information and whether alternative treatments should have been considered.
Another key issue is the adequacy of the advice given to MS regarding the risks of the redo-CABG and alternative treatment options. The extract expressly states that the sufficiency of Dr Tong’s advice was disputed. In Singapore medical negligence jurisprudence, the adequacy of information provided to a patient can be relevant to liability where it bears on whether the treatment was undertaken with proper informed consent or whether the clinician failed to take reasonable steps to ensure the patient understood material risks and alternatives. Even where the case is framed as negligence and breach of contract, the content and sufficiency of medical advice often becomes a factual and legal battleground.
How Did the Court Analyse the Issues?
The court began by setting out the medical and procedural context necessary to evaluate liability. It identified Dr Tong as the primary physician during the post-surgery period and described the timeline of MS’s cardiac events, diagnostic procedures, and surgeries. This approach is typical in medical negligence cases: the court must understand the clinical facts, including what was known at the time of decision-making, what options were available, and what risks were inherent in the chosen intervention.
In analysing the standard of care and breach, the court would necessarily examine what a reasonably competent cardiothoracic surgeon would have done in similar circumstances, particularly given the heightened risk profile of redo-CABG performed soon after an initial CABG. The extract underscores that the increased risk was not disputed: a redo-CABG within a short period involves heavier blood loss due to scarring, adhesions, and vascularised incision tissue. This sets the stage for evaluating whether Dr Tong’s decision-making and surgical planning met the required standard, and whether the risks were properly communicated and managed.
The extract also indicates that the court treated the patency of the LIMA-LAD graft as a significant disputed fact. The patency of the graft supplying the LAD territory would affect the extent of viable myocardium at risk and the potential benefit of revascularisation. If the LIMA-LAD graft remained patent, the clinical urgency and expected benefit of redoing other grafts might differ from a scenario where the LIMA-LAD was also occluded. Consequently, the court’s reasoning would likely have focused on whether the diagnostic interpretation and clinical conclusion about graft status were reasonable, and whether they supported the decision to proceed with redo-CABG rather than other options.
Further, the court would have had to consider causation, even though the trial was confined to liability. In medical negligence, causation is often intertwined with breach: if the alleged breach relates to the choice of treatment, the court must assess whether the chosen treatment caused the death or whether the death would likely have occurred regardless. The extract notes that MS died on 23 April 2007 from post-operative complications. The court’s later reasoning (not included in the extract) would therefore likely have addressed whether the complications were within the known risks of redo-CABG, whether they were preventable through reasonable care, and whether any failure in advice or treatment materially contributed to the fatal outcome.
Finally, the court’s analysis would have addressed the plaintiff’s dual framing in tort and contract. While the legal tests for negligence and breach of contract may differ in formulation, both can turn on whether the defendant’s conduct fell below an appropriate standard and whether that conduct caused the loss. The Civil Law Act provisions invoked by the plaintiff determine the beneficiaries and heads of damages, but the substantive liability analysis remains anchored in medical negligence principles and contractual duties (to the extent pleaded) relating to advice, care, and treatment.
What Was the Outcome?
The provided extract does not include the court’s final orders or its ultimate determination on liability. Accordingly, based solely on the text supplied, it is not possible to state whether Dr Tong was found liable in negligence and/or breach of contract, or whether the claim was dismissed at the liability stage.
What can be stated from the extract is that the trial proceeded on liability only, and the court reserved judgment. The decision date was 22 August 2011, with Tay Yong Kwang J delivering the judgment. For a complete assessment of the outcome, the remaining portions of the judgment (including the findings on breach, causation, and any discussion of damages or apportionment) would need to be reviewed.
Why Does This Case Matter?
This case matters because it illustrates how Singapore courts approach complex medical negligence claims involving high-risk surgical decisions and disputed clinical facts. Redo-CABG performed soon after an initial CABG is inherently dangerous, and the court’s framing highlights that the increased risk was recognised even by the defendant. For practitioners, the case underscores that when a clinician proposes a high-risk intervention, liability may turn not only on the technical execution but also on the reasonableness of the indication for surgery and the adequacy of the advice given to the patient about risks and alternatives.
From a litigation strategy perspective, the decision also demonstrates the importance of disputed diagnostic and clinical interpretation issues—here, the patency of a key graft (the LIMA-LAD). Where the clinical decision depends on whether a particular vessel or graft is open, the factual determination of graft status can become decisive for both breach and causation. Medical experts and counsel must therefore focus on how diagnostic findings were interpreted at the time of decision-making, and whether the chosen treatment aligned with accepted clinical practice.
Finally, the case is relevant to the use of the Civil Law Act in structuring claims by dependants and estates. The plaintiff’s standing as administratrix and the reliance on ss 10, 20 and 21 reflect the statutory mechanism for recovering damages for wrongful death and related losses. While these provisions do not determine liability, they shape the beneficiaries and the practical consequences of a finding of liability, which is crucial for both claimants and defendants in medical negligence litigation.
Legislation Referenced
Cases Cited
- [2011] SGHC 193 (as provided in the metadata; no other cited cases are included in the extract)
Source Documents
This article analyses [2011] SGHC 193 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.